Neck Dissection

• 

  Subject Areas on Research

  • ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas. 
  • Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. 
  • Anterior ischemic optic neuropathy following neck dissection. 
  • BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. 
  • Botulinum toxin injection for postlaryngectomy tracheoesophageal speech failure. 
  • Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. 
  • Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue. 
  • Complications of Bilateral Neck Dissection in Thyroid Cancer From a Single High-Volume Center. 
  • Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum. 
  • Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group Phase II Study (HN-53). 
  • Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma. 
  • External beam radiation followed by planned neck dissection and brachytherapy for base of tongue squamous cell carcinoma. 
  • Extracapsular spread and the perineural extension of squamous cell cancer in the cervical plexus. 
  • Head and neck cancer. Introduction. 
  • High-risk cutaneous squamous cell carcinoma without palpable lymphadenopathy: is there a therapeutic role for elective neck dissection? 
  • Image-Guided Placement of Osseointegrated Implants for Challenging Auricular, Orbital, and Rhinectomy Defects. 
  • Incidental metastatic papillary thyroid carcinoma in microvascular reconstruction. 
  • Insular thyroid cancer: a population-level analysis of patient characteristics and predictors of survival. 
  • Is there a role for selective neck dissection after chemoradiation for head and neck cancer? 
  • Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. 
  • Neck dissection followed by chemoradiotherapy for stage IV (N+) oropharynx cancer. 
  • Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer. 
  • Oncologic effectiveness of selective neck dissection in the N0 irradiated neck. 
  • Pain, quality of life, and spinal accessory nerve status after neck dissection. 
  • Planned early neck dissection before radiation for persistent neck nodes after induction chemotherapy. 
  • Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system. 
  • Prospective studies of neck dissection specimens support preservation of sublevel IIB for laryngeal squamous carcinoma with clinically negative neck. 
  • Recurrence rates after selective neck dissection in the N0 irradiated neck. 
  • Robotic thyroidectomy: do it well or don't do it. 
  • Selective neck dissection for the treatment of neck metastasis from squamous cell carcinoma of the head and neck. 
  • Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: long-term results of two sequential brown university oncology group chemoradiotherapy studies. 
  • Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. 
  • Sentinel node biopsy for head and neck melanoma: a systematic review. 
  • The effect of lateral neck dissection on complication rate for total thyroidectomy. 
  • Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck. 
  • Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? 
  • [(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial. 
• 

  Keywords of People

  • Esclamado, Ramon Mitra, Professor Emeritus of Head and Neck Surgery and Communication Sciences, Head and Neck Surgery & Communication Sciences
  • Lee, Walter T, Professor of Head and Neck Surgery & Communication Sciences, Radiation Oncology
  • Raynor, Eileen Margolies, Associate Professor of Head and Neck Surgery and Communication Sciences, Pediatrics